Dr Glenn Corr, Chief Operating Officer, TauRx discussed the difference that ONE has made to the Life Sciences cluster in the region and the focus that the BioHub brings for the sector as home to 400 scientific entrepreneurs developing new treatments, products and digital solutions for modern healthcare challenges.
TauRx are a pioneering clinical-stage drug development company and a global leader in Alzheimer’s disease research. With their research base in Aberdeen, their mission is to discover, develop and commercialise innovative products for the diagnosis, treatment and cure of neurodegenerative diseases caused through protein aggregation.
Your privacy matters to us so if you want to find out more on how we keep your data safe, view our Privacy Notice or talk to ONE direct.
Opportunity North East Ltd
11 Queens Gardens